Erythropoietin for Neuroprotection in Neonatal Encephalopathy: Safety and Pharmacokinetics

OBJECTIVE: To determine the safety and pharmacokinetics of erythropoietin (Epo) given in conjunction with hypothermia for hypoxic-ischemic encephalopathy (HIE). We hypothesized that high dose Epo would produce plasma concentrations that are neuroprotective in animal studies (ie, maximum concentratio...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Wu, Yvonne W., Bauer, Larry A., Ballard, Roberta A., Ferriero, Donna M., Glidden, David V., Mayock, Dennis E., Chang, Taeun, Durand, David J., Song, Dongli, Bonifacio, Sonia L., Gonzalez, Fernando F., Glass, Hannah C., Juul, Sandra E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Academy of Pediatrics 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3457622/
https://ncbi.nlm.nih.gov/pubmed/23008465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2012-0498
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi